Reference : Adiponectin Fails in Improving Angiogenic Repair in Streptozocin-Treated or Lepr db/d...
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/10993/27287
Adiponectin Fails in Improving Angiogenic Repair in Streptozocin-Treated or Lepr db/db Mice after Hind Limb Ischemia
English
Belisle, Kurt [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Andrassy, Martin [> >]
Schneider, Jochen mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Schiekofer, Stephan [> >]
2012
ISRN (International Scholarly Research Network) Vascular Medicine
2012
Yes
[en] Type 1 and 2 diabetes carry risk factors for the development of microvascular diseases with associated impairment of angiogenic repair. Here, we investigated whether adiponectin, an adipocyte-specific adipocytokine with antiatherosclerotic and antidiabetic properties, regulates angiogenic repair in response to tissue ischemia in Leprdb/db and streptozocin-treated diabetic mouse models. Methods. Adenoviral vectors containing the gene for β-galactosidase, full-length mouse adiponectin, and dominant-negative AMPKα2 were used in streptozocin-treated male Leprdb/db mice, after which hind limb blood flow was measured using a laser doppler blood flow analyzer. Results. The angiogenic repair of ischemic hind limbs was impaired in both streptozocin-treated and Leprdb/db mice compared to wild-type mice as evaluated by laser doppler flow and capillary density analyses. Adenovirus-mediated administration of adiponectin accelerated angiogenic repair after hind limb ischemia in WT mice, but not in Leprdb/db mice or mice treated with streptozocin. In vitro experiments using HUVECs highlighted the antiapoptotic and proangiogenic properties of adiponectin but could not demonstrate accelerated differentiation of endothelial cells into tube- like structures at elevated glucose levels. Conclusions. External administration of adiponectin at elevated glucose levels may not be useful in the treatment of diabetes mellitus-related vascular deficiency diseases.
Luxembourg Centre for Systems Biomedicine (LCSB): Medical Translational Research (J. Schneider Group)
http://hdl.handle.net/10993/27287
10.5402/2012/769092
Article ID 769092

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Belisle, Andrassy, Jochen Schneider2012.pdfPublisher postprint1.81 MBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.